Bioceramic-Coated Textile Products for Consistent Osteointegration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Uncoated textile constructs made from synthetic polymers exhibit poor bonding to bone, leading to issues like fibrous tissue encapsulation, implant loosening, and instability due to inadequate osteointegration, and bioactive ceramic coatings face challenges with adherence and consistency, affecting tissue reactions.

Innovation Solution

A method for manufacturing a homogeneously coated textile product with a biocompatible polymer and bioceramic particles, using Energy Dispersive X-Ray Spectroscopy (EDS) to ensure a homogeneity osteoconductive ratio of 4.7 wt%, and establishing quality control criteria for consistent bioactive response.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If uncoated textile constructs made from synthetic polymers are used, then the implant is simple and easy to manufacture, but the bonding to bone is poor leading to fibrous tissue encapsulation and implant loosening

Engineering Contradiction:
Improveease of manufactureVSAvoidbonding to bone
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent applies composite materials by coating synthetic polymer textile constructs with bioactive ceramic particles. This creates a composite structure where the synthetic polymer provides mechanical properties and the bioactive ceramic particles enable bone bonding, thus resolving the contradiction between ease of manufacture and bonding reliability.

Inventive Principle:
Principle #40Composite materials

2Reliability

If bioactive ceramic coatings are applied to improve bone bonding, then the healing response is enhanced, but the coating consistency and adherence are poor leading to non-induction of expected biocompatible behavior

Engineering Contradiction:
Improvehealing responseVSAvoidcoating consistency
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent employs parameter changes by optimizing coating parameters such as particle size distribution, coating thickness, and ceramic-to-polymer ratio to achieve consistent and homogeneous coatings. This resolves the contradiction between enhanced healing response and poor coating consistency.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent applies local quality by ensuring uniform distribution of bioactive ceramic particles throughout the coating layer, creating consistent local properties across the entire implant surface. This addresses the coating consistency issue while maintaining the enhanced healing response.

Inventive Principle:
Principle #3Local quality

3Reliability

If a homogeneous bioceramic coating is achieved, then the osteointegration is improved, but the manufacturing process becomes more complex requiring quality control inspections

Engineering Contradiction:
ImproveosteointegrationVSAvoidmanufacturing process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by establishing quality control inspection criteria before final product release. This includes pre-defining acceptance criteria for coating homogeneity and conducting inspections during manufacturing, thus achieving improved osteointegration while managing manufacturing complexity through proactive quality control.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method ensures a consistent, enhanced bioactive response with improved osteointegration, reduced implant enlargement, and antimicrobial properties, promoting stable bone-tissue bonding and reduced inflammation.

Implementation Method 1

Energy Dispersive X-Ray Spectroscopy (EDS) on at least one predetermined location along a length of the coated textile product

Methodology Applied
Scientific EffectX-Ray Spectroscopy: X-Ray

Data Source

PatentUS20250269095A1Methods of characterizing a bioactive coated product
Publication Date: 2025.08.28 RIVERPOINT MEDICAL LLC
  • US20250269095A1 patent drawing
  • US20250269095A1 patent drawing
  • US20250269095A1 patent drawing

AI summary

The disclosed inventions relate to an improved bioceramic coated product and methods of characterizing coated products. More specifically, the disclosed inventions relate to an improved bioceramic coated product comprising bioceramic particles that has a homogeneous or uniform application that should reliably provide consistent healing response properties after implantation. The consistent healing responses may include enhanced osteoconductive properties or bone growth, antimicrobial activity, and/or angiogenic activity.